Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2013 June;61(3) > Minerva Cardioangiologica 2013 June;61(3):295-300

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

  INTERVENTIONAL INNOVATIONS: NOVEL THERAPIES AND THE BEST NEW DEVICE CONCEPTS FOR 2013


Minerva Cardioangiologica 2013 June;61(3):295-300

language: English

MitraClip Registries: what have we learned recently

Maisano F.

Cardiothoracic Department, San Raffaele Hospital, Milan, Italy


PDF  


MitraClip therapy is emerging as an alternative treatment for primary and secondary mitral regurgitation in high risk patients. A randomized trial has shown safety in selected patients, with efficacy non inferior to surgery in elderly patients with functional mitral regurgitation. Following commercialization, MitraClip therapy is offered to patients very different from the profile of those enrolled in the randomized trial. Several registries are on the way and provide useful preliminary information related to real-world experience with percutaneous mitral valve repair with the MitraClip system.

top of page

Publication History

Cite this article as

Corresponding author e-mail

francesco.maisano@hsr.it